- Role
- Country
- Date of registration
- Address
CN-MF-000047100Anti-Human CD3 Antibody is an IVDD-legacy in vitro diagnostic registered in EUDAMED. It is classified as IVDD — General. Manufactured by Chengdu Legend-Tec Technology Co.,Ltd. Placed on the EU market in Spain. Explore certificates, regulatory status and the EUDAMED record on MD Atlas.
EUDAMED last updated this device on Jul 22, 2026
B-06977357002411Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
(01)06977357002411
1 warning recorded — scroll inside the panel to see all entries.
Sterile
A sterile device is supplied free of viable micro-organisms — flagged so that it is handled, stored and used to preserve that sterile state.
Single-use device
A single-use device is intended to be used on one patient during a single procedure and then discarded — not reprocessed or reused.
Primary placement in Spain; available across 32 countries total.
| Country | On market since | Until |
|---|---|---|
| SpainPrimary placement | Aug 1, 2022 | Still on market |
| Austria | Aug 1, 2022 | Still on market |
| Belgium | Aug 1, 2022 | Still on market |
| Bulgaria | Aug 1, 2022 | Still on market |
| Cyprus | Aug 1, 2022 | Still on market |
| Czechia | Aug 1, 2022 | Still on market |
| Germany | Aug 1, 2022 | Still on market |
| Denmark | Aug 1, 2022 | Still on market |
| Estonia | Aug 1, 2022 | Still on market |
| EL | Aug 1, 2022 | Still on market |
| Finland | Aug 1, 2022 | Still on market |
| France | Aug 1, 2022 | Still on market |
| Croatia | Aug 1, 2022 | Still on market |
| Hungary | Aug 1, 2022 | Still on market |
| Ireland | Aug 1, 2022 | Still on market |
| Iceland | Aug 1, 2022 | Still on market |
| Italy | Aug 1, 2022 | Still on market |
| Liechtenstein | Aug 1, 2022 | Still on market |
| Lithuania | Aug 1, 2022 | Still on market |
| Luxembourg | Aug 1, 2022 | Still on market |
| Latvia | Aug 1, 2022 | Still on market |
| Malta | Aug 1, 2022 | Still on market |
| Netherlands | Aug 1, 2022 | Still on market |
| Norway | Aug 1, 2022 | Still on market |
| Poland | Aug 1, 2022 | Still on market |
| Portugal | Aug 1, 2022 | Still on market |
| Romania | Aug 1, 2022 | Still on market |
| Sweden | Aug 1, 2022 | Still on market |
| Slovenia | Aug 1, 2022 | Still on market |
| Slovakia | Aug 1, 2022 | Still on market |
| Türkiye | Aug 1, 2022 | Still on market |
| XI | Aug 1, 2022 | Still on market |
Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
06977357002411Basic UDI-DI
The Basic UDI-DI is the main identifier that groups together all device variants of the same model — the regulatory "family" key.
B-06977357002411LGDR0029UDI issuing entities
Issuing entities are the organisations the European Commission has designated to assign Unique Device Identifiers under the EU's UDI system.
IVDR risk classes
IVDR risk classes rank in-vitro diagnostic devices from lowest risk (Class A) to highest (Class D), based on the patient and public-health risk of a wrong result.
European Medical Device Nomenclature — the EU product classification assigned to this device.
W0103080106ANTIBODIES FOR LYMPHOCYTE SUBTYPINGNo certificate specifically references this device's Basic UDI-DI.
B-06977357002404On the marketAnti-Human CD3 AntibodyB-06977357002480On the marketAnti-Human CD3 AntibodyB-06977357002312On the marketAnti-Human CD3 AntibodyB-06977357002244On the marketAnti-Human CD3 AntibodyB-06977357002442On the marketAnti-Human CD3 AntibodyB-06977357002251On the marketNo certificates registered for this manufacturer.
No certificate references this Basic UDI-DI, because: • It does not require a certificate, or • It only requires a certificate without a Basic UDI-DI reference (e.g. a QMS certificate), or • The required certificate(s) referencing this Basic UDI-DI have not been registered yet.